STOCKHOLM, Oct. 26, 2018 /PRNewswire/ --
Third Quarter
- Revenue increased by 16.3% to €167.4m (€144.0m). Organic
revenue grew by 13.8%.
- Operating profit amounted to €7.4m (€8.5m), representing an
operating margin of 4.4% (5.9%).
- Net profit amounted to €6.2m (€4.3m), which represents a net
profit margin of 3.7% (3.0%).
- Cash flow from operating activities amounted to €21.8m
(€15.3m).
- Basic/diluted earnings per share (EPS) were €0.042
(€0.030).
- EBITDA increased by 0.7% to €15.1m (€15.0m), corresponding to
an EBITDA margin of 9.0% (10.4%).
Nine Months
- Revenue increased by 14.7% to €490.4m (€427.5m). Organic
revenue grew by 13.9%.
- Net profit amounted to €22.6m (€11.0m), which represents a net
profit margin of 4.6% (2.6%).
- EBITDA increased by 7.9% to €43.6m (€40.4m), corresponding to
an EBITDA margin of 8.9% (9.5%)
REVENUE AND EARNINGS
|
€ millions
(€m)
|
Q3
2018
|
Q3
2017
|
Growth
|
9M
2018
|
9M
2017
|
Growth
|
FY
2017
|
|
Revenue
|
167.4
|
144.0
|
16%
|
490.4
|
427.5
|
15%
|
580.2
|
|
Operating
profit
|
7.4
|
8.5
|
-13%
|
21.9
|
21.0
|
4%
|
28.8
|
|
Operating profit
margin, %
|
4.4%
|
5.9%
|
|
4.5%
|
4.9%
|
|
5.0%
|
|
Net profit
|
6.2
|
4.3
|
44%
|
22.6
|
11.0
|
105%
|
20.2
|
|
Net profit margin,
%
|
3.7%
|
3.0%
|
|
4.6%
|
2.6%
|
|
3.5%
|
|
Earnings per share,
€
|
0.042
|
0.030
|
40%
|
0.159
|
0.085
|
87%
|
0.157
|
|
Diluted earnings per
share, €
|
0.042
|
0.030
|
40%
|
0.159
|
0.085
|
87%
|
0.157
|
|
|
|
|
|
|
|
|
|
EBITDA
|
15.1
|
15.0
|
1%
|
43.6
|
40.4
|
8%
|
55.0
|
|
EBITDA margin,
%
|
9.0%
|
10.4%
|
|
8.9%
|
9.5%
|
|
9.5%
|
For Alternative Performance Measure definitions and
reconciliations, refer to note 8
Contact information
For further
information, please contact:
Paula Treutiger, Director Corporate Communications & Investor
Relations
Phone: +46-73-366-65-99
E-mail: paula.treutiger@medicover.com
This information is information that Medicover AB is obliged to
make public pursuant to the EU Market Abuse Regulation and the
Securities Markets Act. The information was submitted for
publication, through the agency of the contact person set out
below, at 8.00 (CEST) on 26 October
2018. This interim report and other information about
Medicover, is available at medicover.com.
Medicover is a leading international healthcare and
diagnostic services company and was founded in 1995. Medicover
operates a large number of ambulatory clinics, hospitals,
specialty-care facilities and laboratories and the largest markets
are Poland and Germany. In 2017, Medicover had revenue around
€580 million and 15,900 employees. For more information, go to
www.medicover.com.
This information was brought to you by Cision
http://news.cision.com
http://news.cision.com/medicover/r/interim-report-july-september-2018,c2655072
The following files are available for download:
|
http://mb.cision.com/Main/15662/2655072/933358.pdf
|
Interim report
July-September
|
